Investigation Reveals Sexual Assault of Adolescents in Federally Funded Research Study

An internal investigation has revealed why the $8.8 million Purdue University study was abruptly terminated earlier this year.

Written byKatarina Zimmer
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Purdue University CampusISTOCK, PURDUE9394An investigation into a $8.8 million research study in adolescents at Purdue University that was terminated this summer has revealed more than 30 incidents of threats, violence, or sexual abuse amongst study participants.

The study was funded by the National Institutes of Health and the Centers for Disease Control and Prevention, according to the Journal & Courier. It was launched to assess the effects of a low sodium diet on blood pressure and cholesterol in adolescents. To do so it had recruited 78 children between the ages of 11 and 15 to take part in the four-week camp-like study at Purdue, known as Camp DASH (Dietary Approaches to Stop Hypertension).

The investigation, which was released yesterday (December 3), followed multiple incidents reported to the police in the first few weeks of the study. The allegations included possible molestations, and an incident where a study participant injured another with a hot sauna rock, according to the Journal & Courier. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • katya katarina zimmer

    After a year teaching an algorithm to differentiate between the echolocation calls of different bat species, Katarina decided she was simply too greedy to focus on one field of science and wanted to write about all of them. Following an internship with The Scientist in 2017, she’s been happily freelancing for a number of publications, covering everything from climate change to oncology. Katarina is a news correspondent for The Scientist and contributes occasional features to the magazine. Find her on Twitter @katarinazimmer and read her work on her website.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies